Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
TECH Stock Summary
Top 10 Correlated ETFs
TECH
In the News
TECH Financial details
Company Rating
Strong Buy
Market Cap
10.49B
Income
224.16M
Revenue
1.14B
Book val./share
12.46
Cash/share
0.86
Dividend
0.32
Dividend %
0.44%
Employees
3.2K
Optionable
No
Shortable
Yes
Earnings
01 May 2024
P/E
46.14
Forward P/E
-
PEG
-25.75
P/S
9.95
P/B
5.7
P/C
73.28
P/FCF
52.85
Quick Ratio
2.76
Current Ratio
4.63
Debt / Equity
0.28
LT Debt / Equity
0.28
-
-
EPS (TTM)
1.42
EPS next Y
-
EPS next Q
-
EPS this Y
4.62%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
23.11%
Revenue last 5Y
9.75%
Revenue Q/Q
-1.57%
EPS Q/Q
-46.88%
-
-
-
-
SMA20
-6.94%
SMA50
-2.9%
SMA100
8.06%
Inst Own
73.53%
Inst Trans
0.78%
ROA
9%
ROE
13%
ROC
0.11%
Gross Margin
68%
Oper. Margin
26%
Profit Margin
22%
Payout
20%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
51.79-89.91
52W High
-29.19%
52W Low
+23.58%
RSI
33
Rel Volume
0.52
Avg Volume
1.09M
Volume
565.5K
Perf Week
-11.52%
Perf Month
-15.61%
Perf Quarter
2.85%
Perf Half Y
-8.1%
-
-
-
-
Beta
1.216
-
-
Volatility
2.32%, 3.44%
Prev Close
-1.54%
Price
63.025
Change
-3.47%
TECH Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-06-30
Metric | History | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 4.72 | 4.83 | 6.01 | 7.05 | 7.23 | |
Net income per share | 0.64 | 1.5 | 0.91 | 1.73 | 1.81 | |
Operating cash flow per share | 1.2 | 1.34 | 2.27 | 2.07 | 1.62 | |
Free cash flow per share | 1.03 | 1 | 1.99 | 1.79 | 1.38 | |
Cash per share | 1.1 | 1.77 | 1.49 | 1.57 | 1.3 | |
Book value per share | 7.71 | 9.04 | 10.14 | 10.84 | 12.51 | |
Tangible book value per share | -0.97 | 0.89 | 0.72 | 2.21 | 3.56 | |
Share holders equity per share | 7.71 | 9.04 | 10.14 | 10.84 | 12.51 | |
Interest debt per share | 3.49 | 2.96 | 2.8 | 2.15 | 2.82 | |
Market cap | 7.91B | 10.09B | 17.45B | 13.59B | 12.83B | |
Enterprise value | 8.31B | 10.38B | 17.67B | 13.75B | 13.1B | |
P/E ratio | 82.29 | 44 | 124.26 | 49.97 | 44.98 | |
Price to sales ratio | 11.07 | 13.66 | 18.74 | 12.3 | 11.29 | |
POCF ratio | 43.53 | 49.16 | 49.54 | 41.8 | 50.44 | |
PFCF ratio | 50.61 | 65.73 | 56.67 | 48.49 | 59.36 | |
P/B Ratio | 6.78 | 7.3 | 11.1 | 7.99 | 6.52 | |
PTB ratio | 6.78 | 7.3 | 11.1 | 7.99 | 6.52 | |
EV to sales | 11.64 | 14.05 | 18.98 | 12.44 | 11.53 | |
Enterprise value over EBITDA | 56.64 | 65.91 | 74.46 | 34.57 | 32.26 | |
EV to operating cash flow | 45.75 | 50.56 | 50.17 | 42.27 | 51.51 | |
EV to free cash flow | 53.2 | 67.6 | 57.39 | 49.04 | 60.63 | |
Earnings yield | 0.01 | 0.02 | 0.01 | 0.02 | 0.02 | |
Free cash flow yield | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Debt to equity | 0.43 | 0.31 | 0.27 | 0.19 | 0.23 | |
Debt to assets | 0.27 | 0.21 | 0.19 | 0.14 | 0.17 | |
Net debt to EBITDA | 2.76 | 1.82 | 0.93 | 0.39 | 0.68 | |
Current ratio | 4.05 | 4.88 | 3.35 | 3.44 | 4.84 | |
Interest coverage | 5.79 | 3.89 | 10.72 | 26.23 | -26.66 | |
Income quality | 1.89 | 0.89 | 2.52 | 1.24 | 0.89 | |
Dividend Yield | 0.01 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.5 | 0.21 | 0.35 | 0.18 | 0.18 | |
Sales general and administrative to revenue | 0.33 | 0.33 | 0.31 | 0.31 | 0.31 | |
Research and developement to revenue | 0.09 | 0.09 | 0.08 | 0.08 | 0.08 | |
Intangibles to total assets | 0.7 | 0.61 | 0.64 | 0.59 | 0.53 | |
Capex to operating cash flow | -0.14 | -0.25 | -0.13 | -0.14 | -0.15 | |
Capex to revenue | -0.04 | -0.07 | -0.05 | -0.04 | -0.03 | |
Capex to depreciation | -0.33 | -0.63 | -0.5 | -0.44 | -0.36 | |
Stock based compensation to revenue | 0.05 | 0.04 | 0.05 | 0.04 | 0.03 | |
Graham number | 10.5 | 17.47 | 14.38 | 20.57 | 22.6 | |
ROIC | 0.06 | 0.03 | 0.07 | 0.12 | 0.1 | |
Return on tangible assets | 0.17 | 0.29 | 0.17 | 0.29 | 0.23 | |
Graham Net | -2.67 | -1.52 | -1.89 | -0.83 | -1.39 | |
Working capital | 310.62M | 414.25M | 358.32M | 429.54M | 492.97M | |
Tangible asset value | -146.51M | 136.34M | 112.2M | 347.39M | 559.13M | |
Net current asset value | -306.21M | -125.48M | -181.12M | 11.76M | -50.69M | |
Invested capital | 0.43 | 0.31 | 0.27 | 0.19 | 0.23 | |
Average receivables | 128.88M | 130M | 133.96M | 169.97M | 206.51M | |
Average payables | 67.4M | 67.25M | 79.62M | 104.83M | 95.51M | |
Average inventory | 88.35M | 97.1M | 109.95M | 128.94M | 156.38M | |
Days sales outstanding | 70.27 | 60.55 | 57 | 64.23 | 70.15 | |
Days payables outstanding | 108.11 | 90.39 | 117.46 | 118.88 | 76.91 | |
Days of inventory on hand | 138.18 | 147.36 | 142.91 | 147.55 | 170.76 | |
Receivables turnover | 5.19 | 6.03 | 6.4 | 5.68 | 5.2 | |
Payables turnover | 3.38 | 4.04 | 3.11 | 3.07 | 4.75 | |
Inventory turnover | 2.64 | 2.48 | 2.55 | 2.47 | 2.14 | |
ROE | 0.08 | 0.17 | 0.09 | 0.16 | 0.15 | |
Capex per share | -0.17 | -0.34 | -0.29 | -0.29 | -0.24 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q2
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.73 | 1.87 | 1.91 | 1.75 | 1.73 | |
Net income per share | 0.32 | 0.45 | 0.48 | 0.32 | 0.17 | |
Operating cash flow per share | 0.41 | 0.32 | 0.53 | 0.38 | 0.53 | |
Free cash flow per share | 0.37 | 0.25 | 0.46 | 0.29 | 0.43 | |
Cash per share | 1.25 | 1 | 1.3 | 0.94 | 0.86 | |
Book value per share | 11.64 | 12.01 | 12.49 | 12.63 | 12.46 | |
Tangible book value per share | 2.48 | 2.96 | 3.55 | 2.84 | 2.75 | |
Share holders equity per share | 11.64 | 12.01 | 12.49 | 12.63 | 12.46 | |
Interest debt per share | 1.86 | 3.01 | 2.91 | 3.51 | 3.55 | |
Market cap | 13.01B | 11.67B | 12.86B | 10.76B | 12.16B | |
Enterprise value | 13.14B | 12.02B | 13.13B | 11.16B | 12.58B | |
P/E ratio | 65.06 | 41.55 | 42.58 | 52.77 | 110.64 | |
Price to sales ratio | 47.92 | 39.68 | 42.67 | 38.87 | 44.59 | |
POCF ratio | 202.12 | 230.95 | 154.17 | 181.26 | 146.24 | |
PFCF ratio | 223.3 | 300.9 | 177.19 | 235.07 | 178.09 | |
P/B Ratio | 7.12 | 6.18 | 6.54 | 5.39 | 6.19 | |
PTB ratio | 7.12 | 6.18 | 6.54 | 5.39 | 6.19 | |
EV to sales | 48.37 | 40.86 | 43.58 | 40.32 | 46.15 | |
Enterprise value over EBITDA | 138.88 | 112.12 | 108.12 | 132.28 | 192.02 | |
EV to operating cash flow | 204.05 | 237.81 | 157.46 | 188.01 | 151.36 | |
EV to free cash flow | 225.44 | 309.84 | 180.97 | 243.82 | 184.33 | |
Earnings yield | 0 | 0.01 | 0.01 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0.01 | 0 | 0.01 | |
Debt to equity | 0.16 | 0.25 | 0.23 | 0.28 | 0.28 | |
Debt to assets | 0.12 | 0.18 | 0.17 | 0.2 | 0.2 | |
Net debt to EBITDA | 1.32 | 3.23 | 2.26 | 4.75 | 6.5 | |
Current ratio | 4.4 | 4.04 | 4.84 | 4.63 | 4.37 | |
Interest coverage | 28.82 | 5.35K | 25.53 | 11.42 | 8.78 | |
Income quality | 1.29 | 0.72 | 1.1 | 1.16 | 3.03 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.25 | 0.18 | 0.17 | 0.25 | 0.46 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.08 | 0.08 | 0.08 | 0.09 | 0.08 | |
Intangibles to total assets | 0.61 | 0.55 | 0.53 | 0.56 | 0.56 | |
Capex to operating cash flow | -0.09 | -0.23 | -0.13 | -0.23 | -0.18 | |
Capex to revenue | -0.02 | -0.04 | -0.04 | -0.05 | -0.05 | |
Capex to depreciation | -0.23 | -0.44 | -0.4 | -0.48 | -0.53 | |
Stock based compensation to revenue | 0.06 | 0.03 | -0.01 | 0.04 | 0.05 | |
Graham number | 9.13 | 10.98 | 11.6 | 9.57 | 6.99 | |
ROIC | 0.02 | 0.03 | 0.03 | 0.02 | 0.01 | |
Return on tangible assets | 0.05 | 0.06 | 0.06 | 0.04 | 0.02 | |
Graham Net | -0.77 | -1.94 | -1.39 | -2.29 | -2.45 | |
Working capital | 436.79M | 429.83M | 492.97M | 463.72M | 455.41M | |
Tangible asset value | 389.87M | 465.89M | 559.13M | 449.4M | 432.87M | |
Net current asset value | 28.89M | -139.01M | -50.69M | -166.14M | -176.55M | |
Invested capital | 0.16 | 0.25 | 0.23 | 0.28 | 0.28 | |
Average receivables | 179.47M | 200.59M | 217.44M | 211.52M | 206.01M | |
Average payables | 72.92M | 75.15M | 79.29M | 78.11M | 55.21M | |
Average inventory | 155.12M | 164.85M | 170.55M | 178.86M | 183.46M | |
Days sales outstanding | 61.23 | 66.22 | 65.25 | 66.48 | 68.49 | |
Days payables outstanding | 70.4 | 79.53 | 72.01 | 77.41 | 29.54 | |
Days of inventory on hand | 163.46 | 165.81 | 159.87 | 182.54 | 169.52 | |
Receivables turnover | 1.47 | 1.36 | 1.38 | 1.35 | 1.31 | |
Payables turnover | 1.28 | 1.13 | 1.25 | 1.16 | 3.05 | |
Inventory turnover | 0.55 | 0.54 | 0.56 | 0.49 | 0.53 | |
ROE | 0.03 | 0.04 | 0.04 | 0.03 | 0.01 | |
Capex per share | -0.04 | -0.07 | -0.07 | -0.09 | -0.09 |
TECH Frequently Asked Questions
What is Bio-Techne Corporation stock symbol ?
Bio-Techne Corporation is a US stock , located in Minneapolis of Mn and trading under the symbol TECH
What is Bio-Techne Corporation stock quote today ?
Bio-Techne Corporation stock price is $63.025 today.
Is Bio-Techne Corporation stock public?
Yes, Bio-Techne Corporation is a publicly traded company.